Humedics Launches 'EASMENT' Plant-Derived Exosome Cosmetics for Clinical Use

Two Products Featuring Exosomes Derived from Tomato and Lithospermum Erythrorhizon

Humedics has expanded its product lineup with plant-derived exosome-based functional cosmetics designed for clinical use.

On June 25, Huons Group’s Humedics announced the launch of two new skin booster cosmetic products, "EASMENT," which incorporate highly purified plant-derived exosomes.

Humedics plant-derived exosome-based functional cosmetics for clinics ‘Isment T’ and ‘Isment G’. Humedics

EASMENT has been developed with the concepts of "Plus Care," to enhance and maintain the effects of procedures, and "Post Care," to support post-procedure skin recovery.

The product lineup consists of two topical options, "Isment T" and "Isment G," which can be selected according to individual skin concerns.

"Isment T" contains exosomes derived from tomato callus and is formulated to help with brightening, soothing, and moisturizing. "Isment G" features exosomes from Lithospermum erythrorhizon (Jicho) callus, focusing on improving pores and regenerating the skin’s protective barrier against damage.

Humedics plans to create greater synergies by linking EASMENT with its existing aesthetic product range. The company has built its portfolio around the filler "Elravie" and the ECM booster "Rituo." It also plans to establish combination protocols to maximize synergy with newly released medical devices like "Dermashine Duo_RF" and the wound dressing "Arche."

With the launch of EASMENT, Humedics has further strengthened its aesthetic business portfolio, expanding from fillers and injectable skin boosters to now include topical skin booster cosmetics.

A Humedics representative stated, "EASMENT is a product that can enhance synergy with Humedics’ existing aesthetic products and medical devices. We will continue to strengthen our market competitiveness based on our diverse aesthetic portfolio."

This content was produced with the assistance of AI translation services.